GW Pharmaceuticals PLC ADR (USD)
GWPH
Overview
Key Information
Legal Documents
Financials

Overview

SectorHealthcare
Industry-
Day Range105.85 | 109.05
52-Wk Range90.14 | 196.00
Last Close106.62
Mkt Cap (m)3,338.62
Dividend yield-
ISINUS36197T1034
Volume594,670
Exchange VenueNAS

Company Profile

GW Pharmaceuticals PLC is engaged in the research, development and commercialisation of cannabinoid prescription medicines using botanical extracts derived from the Cannabis Sativa plant.

Key Information
Price/Earning-
Price/Book4.58
Price/Sales265.16
P/CF-
Rev Growth (3 year avg)-33.47
EPS Growth (3 year avg)-
Operating Margin % -2267.43
Net Margin %-2317.40
Return on Equity-74.93
Debt/Equity0.00

Legal Documents

Prospectus
en 03/10/2018
Annual Report
en 31/12/2018

Financials

Income Statement
USD201320142015201620172018
Revenue (m)444943131113
Operating Income (m)-17-37-96-146-199-289
Net Income (m)-7-24-68-83-176-295
Basic EPS-0.58-1.36-3.29-3.67-6.98-10.56
Avg. Diluted Shares Outstanding (m)131821232528
Balance Sheet
USD201320142015201620172018
Current Assets (m)78286387527371391
Non Current Assets (m)1728526375100
Total Assets (m)95314439590446491
Current Liabilities (m)212842464959
Total Liabilities (m)------
Total Equity (m)57258372519373415
Cash Flows
USD201320142015201620172018
Operating Cash Flows (m)-12-21-70-110-148-232
Capital Expenditure (m)-4-12-27-12-22-33
Figures are quoted in USD unless stated otherwise
0.00 (0.00%)
$
106.62
Last Price